000			02920nam a2200313Ia 4500
003			MX-MdCICY
005			20250625153931.0
040			_cCICY
090			_aB-13915
245	1	0	_aCharacterization of the degradation mechanisms of lysine-derived aliphatic poly (ester urethane)scaffolds
490	0		_vBioMaterials, 32, p.419--29, 2011
520	3		_aCharacterization of the degradation mechanism of polymeric scaffolds and delivery systems for regenerative medicine is essential to assess their clinical applicability. Key performance criteria include induction of a minimal, transient inflammatory response and controlled degradation to soluble noncytotoxic breakdown products that are cleared from the body by physiological processes. Scaffolds fabricated from biodegradable poly(ester urethane)s (PEURs)undergo controlled degradation to noncytotoxic breakdown products and support the ingrowth of new tissue in preclinical models of tissue regeneration. While previous studies have shown that PEUR scaffolds prepared from ysine-derived polyisocyanates degrade faster under in vivo compared to in vitro conditions, the degradation mechanism is not well understood. In this study, we have shown that PEUR scaffolds prepared from lysine triisocyanate (LTI)or a trimer of hexamethylene diisocyanate (HDIt)undergo hydrolytic, esterolytic, and oxidative degradation. Hydrolysis of ester bonds to yield a-hydroxy acids is the dominant mechanism in buffer, and esterolytic media modestly increase the degradation rate. While HDIt scaffolds show a modest (<20 percent)increase in degradation rate in oxidative medium, LTI scaffolds degrade six times faster in oxidative medium. Furthermore, the in vitro rate of degradation of LTI scaffolds in oxidative medium approximates the in vivo rate in rat excisional wounds, and histological sections show macrophages expressing myeloperoxidase at the material surface. While recent preclinical studies have underscored the potential of injectable PEUR scaffolds and delivery systems for tissue regeneration, this promising class of biomaterials has a limited regulatory history. Elucidation of the macrophage-mediated oxidative mechanism by which LTI scaffolds degrade in vivo provides key insights into the ultimate fate of these materials when injected into the body.
650	1	4	_aPOLYURETHANE
650	1	4	_aBIODEGRADATION
650	1	4	_aMACROPHAGE
650	1	4	_aOXIDATION
650	1	4	_aHYDROLYSIS
650	1	4	_aSCAFFOLD
700	1	2	_aHafeman, A.E.
700	1	2	_aKatarzyna, J.Z.
700	1	2	_aZachman, A.L.
700	1	2	_aHak-Joon, S.
700	1	2	_aNanney, L.B.
700	1	2	_aDavidson, J.M.
700	1	2	_aGuelcher, S.A.
856	4	0	_uhttps://drive.google.com/file/d/165ussLROzZGI1JuM31wBO0FeZbHkV0es/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c48112 _d48112